Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected and healthy individuals

被引：0
|
作者：
Dickinson, Laura [1 ]
Aarons, Leon [2 ]
Back, David [1 ]
Khoo, Saye [1 ]
Else, Laura [1 ]
Waters, Laura [3 ]
Pozniak, Anton [3 ]
Boffito, Marta [3 ]
机构：
[1] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England
[2] Univ Manchester, Sch Pharm & Pharmacal Sci, Manchester, Lancs, England
[3] Chelsea & Westminster Fdn Trust, St Stephens Ctr, London, England
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2009年 / 68卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：304 / 305
页数：2
相关论文
共 50 条
  • [1] Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers
    Dickinson, Laura
    Boffito, Marta
    Back, David
    Waters, Laura
    Else, Laura
    Davies, Geraint
    Khoo, Saye
    Pozniak, Anton
    Aarons, Leon
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (06) : 1233 - 1243
  • [2] Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals
    Dickinson, Laura
    Boffito, Marta
    Back, David J.
    Khoo, Saye H.
    Pozniak, Anton L.
    Mugyenyi, Peter
    Merry, Concepta
    Autar, Reshma Saskia
    Burger, David M.
    Aarons, Leon J.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (06) : 1344 - 1355
  • [3] Population pharmacokinetics (PK) of ritonavir (RTV)-boosted atazanavir (ATV) in HIV-infected and healthy individuals
    Dickinson, L.
    Aarons, L.
    Back, D.
    Waters, L.
    Else, L.
    Khoo, S.
    Pozniak, A.
    Boffito, M.
    [J]. HIV MEDICINE, 2009, 10 : 51 - 52
  • [4] Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients
    Punyawudho, Baralee
    Thammajaruk, Narukjaporn
    Ruxrungtham, Kiat
    Avihingsanon, Anchalee
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (03) : 327 - 332
  • [5] Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients
    Dailly, Eric
    Tribut, Olivier
    Tattevin, Pierre
    Arvieux, Cedric
    Perre, Philippe
    Raffi, Francois
    Jolliet, Pascale
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (07) : 523 - 526
  • [6] Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients
    Eric Dailly
    Olivier Tribut
    Pierre Tattevin
    Cédric Arvieux
    Philippe Perré
    François Raffi
    Pascale Jolliet
    [J]. European Journal of Clinical Pharmacology, 2006, 62 : 523 - 526
  • [7] Ritonavir-Boosted Darunavir Is Rarely Associated with Nephrolithiasis Compared with Ritonavir-Boosted Atazanavir in HIV-Infected Patients
    Nishijima, Takeshi
    Hamada, Yohei
    Watanabe, Koji
    Komatsu, Hirokazu
    Kinai, Ei
    Tsukada, Kunihisa
    Teruya, Katsuji
    Gatanaga, Hiroyuki
    Kikuchi, Yoshimi
    Oka, Shinichi
    [J]. PLOS ONE, 2013, 8 (10):
  • [8] Pharmacokinetic interaction between rifampicin and ritonavir-boosted atazanavir in HIV-infected patients
    Mallolas, J.
    Sarasa, M.
    Nomdedeu, M.
    Soriano, A.
    Lopez-Pua, Y.
    Blanco, J. L.
    Martinez, E.
    Gatell, J. M.
    [J]. HIV MEDICINE, 2007, 8 (02) : 131 - 134
  • [9] Ritonavir-boosted atazanavir may be efficacious in HIV-infected patients concurrently receiving omeprazole
    Chan-Tack, KM
    Edozien, A
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 42 (09) : 1344 - 1344
  • [10] Proton pump inhibitors do not reduce atazanavir concentrations in HIV-infected patients treated with ritonavir-boosted atazanavir
    Guiard-Schmid, JB
    Poirier, JM
    Bonnard, P
    Meynard, JL
    Slama, L
    Lukiana, T
    Jaillon, P
    Pialoux, G
    [J]. AIDS, 2005, 19 (16) : 1937 - 1938
12345